Topic Listing for ALBIREO PHARMA, INC.

Additional Pipeline Opportunities Administration
Agenda Agreements Steiner Pohl
Amendment Amendment Termination
Annual Report Stockholders Approval 2010 Stock Incentive Plan
Audit Committee Audit Committee Report
Auditors Fees Base Salaries Executive Officers Registrant
Base Salary Basis Presentation
Become Involved Lawsuits Administrative Proceedings Protect Defend Enforce Beneficial Ownership Reporting Compliance
Benefits Other Compensation Biodel Inc
Biodel Inc Announces Completion Public Offering Biodel Inc Announces Uspto Office Action Indicating Allowability
Biodel Inc Exact Name Registrant Specified Charter Biodel Inc Reports 2007 Financial Results
Board Committees Board Determination Independence
Board Meetings Attendance Bridge Financing
Business Business Activities Involve Storage Hazardous Materials Require Compliance
Cash Equivalents Certification
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Change Control Agreement Severance Krasner Messrs Michel Bavier
Change Control Agreement Severance Michel Steiner Change Control Agreement Severance Steiner
Change Control Agreements Severance Changes Internal Control Over Financial Reporting
Christopher Columbus Lease Claims Other Parties Infringe Misappropriated Proprietary Technology Result
Clinical Trials Delayed Not Produce Positive Results Incur Code Business Conduct Ethics
Commercial Success Product Candidates Develop Including Viaject Common Stock
Communications Independent Directors Compared 2005
Compared 2006 Compared 2007
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Competition
Components Executive Compensation Program Comprehensive Income Loss
Concentration Risks Uncertainties Condensed Statements Operations Except Share Per Amounts
Consent Independent Registered Public Accounting Firm Consulting Agreement
Consulting Clinical Research Services Consulting Services
Contractual Obligations Controls Procedures
Corporate Governance Corporate Governance Guidelines
Critical Accounting Policies Significant Judgments Estimates Current Treatments Diabetes Limitations
Deferred Compensation Deferred Public Offering Costs
Depend Heavily Success Most Advanced Product Candidate Viaject Diabetes Insulin Market
Diabetes Overview Director Attendance Annual Meeting Stockholders
Director Compensation Director Compensation Table
Director Nomination Process Discretionary Annual Cash Bonuses
Dividends Eligibility Receive Awards
Employee Stock Purchase Plan Employees
Employment Agreements Employment Agreements Steiner Pohl
Equity Awards Equity Compensation Plan Information
Equity Plans Estimated Payments
Estimated Payments Change Control Estimated Severance Payments
Estimates Evaluation Disclosure Controls Procedures
Exact Name Registrant Specified Charter Except Per Share Amounts
Except Share Per Amounts Executive Compensation
Executive Director Compensation Processes Executive Officers Directors Principal Stockholders Ability Control Matters
Executive Officers Directors Principal Stockholders Maintain Ability Control Executive Officers Directors Principal Stockholders Significant Ability Control
Executive Officers Registrant Exercise Warrants
Exhibits Expect Expand Development Regulatory Sales Marketing Capabilities Result
Explanatory Face Substantial Competition Development Product Candidates Result Others
Failure Obtain Regulatory Approval International Jurisdictions Prevent Marketing Fair Value Financial Instruments
Fda Not Believe Product Candidates Satisfy Requirements 505 Federal Income Tax Consequences
Fold Detach Here Read Reverse Side Form 10-k
Form 10-q Former Chief Financial Officer Severance Agreement
Forward-looking Statements Funding Requirements
Future Success Depends Ability Retain Chief Executive Officer General
General Administrative Expenses Governments Outside United States Tend Impose Strict Price
Grants Plan-based Awards Grants Plan-based Awards 2007
Grants Plan-based Awards 2008 Grants Plan-based Awards 2009
Held 2008 1000 Held 2009 900
Held 2010 900 Holders
Householding Annual Meeting Materials Impairment Long-lived Assets
Incentive Stock Options Income Taxes
Incur Substantial Costs Result Operating Public Management Required Incurred Significant Losses Since Inception Expect Incur Foreseeable
Index Index Financial Statements
Index Report Form 10-k Information Directors
Intellectual Property Intellectual Property Proprietary Technology
Interest Income Interest Income Expense
Interest Other Income Issuance Series Convertible Preferred Stock
Leases Legislation Make Difficult Costly Obtain Regulatory Approval Product
Liquidity Capital Resources Managements Annual Report Internal Control Over Financial Reporting
Managements Evaluation Disclosure Controls Procedures Manufacturing
Market Information Market Opportunity
Marketable Securities Material Weaknesses
Need Substantial Additional Funding Unable Raise Capital Needed Net Loss Per Share
Never Paid Cash Dividends Capital Stock Not Anticipate Nominating Corporate Governance Committee
Nominating Governance Committee Nominees Election Directors
Nonstatutory Stock Options Not Able Comply Timely Basis Requirements 404 Sarbanes-oxley
Not Able Obtain Required Regulatory Approvals Commercialize Product Notes Condensed Financial Statements Except Share Per Amounts
Number 001-33451 Number Shares Available Issuance
Objectives Philosophy Executive Compensation Program Offer Letter Michel
Option Exercises Stock Vested Other Information
Other Matters Other Stock-based Awards
Outstanding Equity Awards Year-end Over Existing Insulin Treatments
Overview Overview Executive Compensation Process
Part Phase Insulin Release
Plan Benefits Policies Procedures Related Person Transactions
Potential Advantages Viaject Pre-approval Policies Procedures
Preclinical Study Clinical Trial Accruals Preferred Stock
Principal Accountant Fees Services Product Candidates Found Cause Undesirable Side Effects Need
Product Candidates Rendered Obsolete Technological Change Product Liability Lawsuits Against Cause Incur Substantial Liabilities
Product Obtain Marketing Approval Subject Restrictions Withdrawal Market Property Equipment
Provisions Corporate Charter Documents Delaware Law Make Acquisition Provisions Foreign Participants
Proxy Statement Pursuant Securities Exchange Act 1934
Quantitative Qualitative Disclosures Market Risks Ratification Appointment Independent Registered Public Accounting Firm
Recent Accounting Pronouncements Recent Highlights
Recently Enacted Legislation Make Difficult Costly Obtain Regulatory Registered Direct Equity Offering
Registrants Telephone Number Including Area Code 203 796-5000 Registration Rights
Regulations Outside United States Related Party Loans
Rely Parties Conduct Clinical Trials Those Not Perform Remediation Status
Report Independent Registered Public Accounting Firm Reports Side Effects Safety Concerns Related Technology Fields
Research Development Costs Research Development Expenses
Restricted Stock Awards Restricted Stock Units
Restrictions Repricing Results Early Stage Clinical Trials Not Ensure Success
Results Operations Revenues
Reverse Split Risks Related Dependence Parties
Risks Related Development Commercialization Product Candidates Risks Related Employee Matters Managing Growth
Risks Related Financial Position Need Additional Capital Risks Related Intellectual Property
Rule 14a-101 Safe Harbor
Sales Marketing Saw Mill Road Danbury Connecticut 06810
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Series Convertible Preferred Stock Severance Agreement Reding
Severance Change Control Benefits Share-based Compensation
Shares Reserved Future Issuance Short Operating History Make Difficult Evaluate Success Business
Signatures Significant Portion Total Outstanding Shares Restricted Immediate Resale
Sources Liquidity Cash Flows Special Regarding Forward-looking Statements
Stock Appreciation Rights Stock Incentive Plan Amended
Stock Option Awards Stock Price Volatile Purchasers Common Incur Substantial Losses
Stock-based Compensation Stockholder Proposals Annual Meeting 2009
Stockholder Proposals Annual Meeting 2010 Strategy
Strategy Committee Subject Pricing Pressures Uncertainties Regarding Medicare Reimbursement Reform
Submission Matters Vote Security Holders Subsequent Event
Subsidiaries Registrant Substitute Awards
Summary Compensation Table Summary Registrants Non-employee Director Compensation
Suppliers Principally Sole Insulin Supplier Fail Deliver Materials Tax Consequences
Tax Considerations Timely Sufficient Manner They Fail Comply Applicable Regulations
Transferability Awards Types Awards
Unable Obtain Adequate Reimbursement Governments Third-party Payors Products Unable Protect Intellectual Property Rights Competitors Develop Market
Unregistered Sales Equity Securities Proceeds Viacal
Viadel Viadel Technology
Viaject Viamass
Viatab Voting Procedures
Warrants 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki